Raising capital is one of the most time-consuming and high-stakes activities any startup undertakes. Getting it wrong costs you months, dilution, and momentum. We bring institutional-grade financial expertise to the startup world, having raised over £12M across multiple rounds for our clients.
Building robust, investor-ready financial models that tell your growth story with clarity and credibility.
Creating compelling pitch decks, one-pagers, and data rooms that stand out in a crowded market.
Identifying the right investors for your stage, sector, and geography, and facilitating warm introductions through our network.
Running structured fundraising processes, managing investor communications, and advising on term sheet negotiations.
Preparing and submitting applications to Innovate UK, UKRI, Horizon Europe, and other grant bodies.
Designing financial controls and forecasting systems to extend your runway and reduce burn rate.
Building a STEM product requires navigating a maze of scientific validation, regulatory requirements, and technical development decisions. We bring deep domain expertise across life sciences, health-tech, AI/ML, and medical devices to help you make the right calls at every stage.
Crafting the scientific narrative that underpins your product, aligning clinical evidence with commercial objectives.
Mapping the route to CE marking, FDA clearance, or other regulatory approvals, including pre-submission strategy and documentation.
Developing and validating biomarker strategies for clinical development, companion diagnostics, and precision medicine applications.
Advising on trial design, endpoint selection, patient enrichment strategies, and KOL engagement.
Advising on the integration of artificial intelligence and machine learning across product development, clinical workflows, and business operations. This includes clinical AI validation for regulated environments, AI-driven diagnostic and biomarker strategy, and the design and implementation of agentic AI workflows that help companies automate and accelerate key processes in their products and operations.
Creating structured development plans with clear milestones, risk registers, and go/no-go decision frameworks.
A scientifically sound product with no route to market is a research project, not a business. We help you bridge the gap between development and commercial success, drawing on experience launching products across health-tech, pharma, deep tech, and consumer technology.
Understanding your market landscape, identifying your differentiation, and defining your value proposition.
Planning your market entry, including pricing, channel strategy, partnership development, and initial customer acquisition.
Managing relationships with investors, board members, clinical partners, and regulatory bodies.
Identifying and negotiating strategic partnerships with distributors, healthcare providers, technology platforms, and industry bodies.
Growth creates complexity. We help you build the operational foundations that allow your business to scale without breaking. We also work with companies in distress, bringing turnaround experience and a calm, structured approach to crisis management.
Implementing structured project management frameworks tailored to fast-moving startup environments.
Creating reporting frameworks that keep stakeholders informed and engaged without consuming your team's time.
Building risk registers and mitigation strategies for technical, commercial, and operational risks.
For businesses in difficulty, we provide rapid diagnostic, stabilisation planning, and execution support.
Bringing a systems-design approach to product architecture, consumer pathways, and user experience. Drawing on training at the Bartlett School of Architecture and experience building a technology platform end-to-end as COO, we help companies design products and experiences that are coherent, usable, and built to scale.
For healthtech, medtech, and diagnostics companies, regulatory approval is not a compliance checkbox. It is a strategic milestone that shapes your product roadmap, your fundraising narrative, and your path to commercial revenue. We have direct experience of both CE marking and FDA clearance, and we help you approach the regulatory pathway as an integrated part of your growth strategy, not a siloed workstream.
Mapping the CE marking or FDA clearance route for your product, including pre-submission strategy, evidence requirements, and timeline planning aligned with your commercial objectives.
Preparing the technical documentation, clinical evidence package, and quality management frameworks required for CE marking under MDR and IVDR.
Advising on 510(k), De Novo, or PMA pathways, pre-submission meetings, and the clinical and technical evidence required to support your submission.
Ensuring that regulatory planning is integrated with your product development roadmap, fundraising milestones, and go-to-market timing, not treated as a separate problem.
Designing clinical and analytical validation strategies that satisfy regulatory requirements while generating commercially useful data.
Translating your regulatory pathway into clear, credible language for investor decks, data rooms, and due diligence conversations.